ClinicalTrials.gg
RecruitingNCT06677372Updated Nov 6, 2024

Comparative Analysis of Core Body Temperature Measurement

An interventional study of Body temperature measurement in Temperature Change, Body, sponsored by Seoul National University Hospital. Recruiting at 1 site in Korea, Republic of. Open to participants aged 19 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-06.

Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Device feasibility

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Dec 2023, registered Nov 2024).
  • Started Dec 2023; still recruiting 2 years 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
19 Years to 70 Years
Sex
All
01

Study summary

Comparison and evaluation of the correlation, accuracy, and precision between a skin-attached temperature sensor and the standard method of deep body temperature measurement, the esophageal thermometer, by measuring and assessing both temperature measurement methods.

02

Conditions studied

  • Temperature Change, Body

Keywords

  • Esophageal temperature
  • 3M Spot On
  • Zero heat flux temperature
03

In context

Body Temperature Changes

97 studies on the registry are indexed under Body Temperature Changes; 20 are open to participants now.

This study's planned enrollment of 20 is below the median of 40 across 68 interventional studies indexed under Body Temperature Changes.

Browse Body Temperature Changes studies →

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,900 studies on the registry; 274 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy adults aged 19 years and above, but under 70 years

Exclusion criteria

Exclusion Criteria:

  • Cases where there were serious side effects during a previous examination performed under sedation or anesthesia
  • Currently undergoing treatment for a diagnosed disease
  • Diagnosed with esophageal varices or having a history of esophagitis
  • Having undergone esophageal and gastric resection surgery
05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Healthy subjects

    Diagnostic Test: Body temperature measurement

Interventions

  • Diagnostic testBody temperature measurement

    Comparative analysis of temperature between esophageal temperature and skin temperature

06

What researchers measure

Primary outcomes

  1. Body temperature

    Esophageal Temperature Probe versus Skin Temperature Sensors

    Time frame: From enrollment to the end of the treatment at 1month

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2023 to primary completion in Feb 2024, 2 months.

Of 44 non-industry interventional studies with no phase under Body Temperature Changes, half reached primary completion within 5 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 21. This study's 2 months is below that.

Counting every sponsor, half of 44 studies reached it within 5 months; a quarter within 3 and three quarters within 21.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 2, 2024
First posted
Nov 6, 2024
StartActual
Dec 1, 2023
Primary completionActual
Feb 29, 2024
CompletionEst.
Jun 30, 2025
Last update
Nov 6, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06677372
Responsible party
Su Jong Yu (Professor, Seoul National University Hospital) — Principal investigator
First posted
Nov 6, 2024
Start date
Dec 1, 2023
Primary completion
Feb 29, 2024
Completion
Jun 30, 2025 (estimated)
Last update
Nov 6, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion